Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors

Clinical trial NCT01525082 · COMPLETED

Trial details

NCT number: NCT01525082
Sponsor: Shaheen Shagufta
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrinoma Glucagonoma Insulinoma Pancreatic Polypeptide Tumor Recurrent Islet Cell Carcinoma Recurrent Pancreatic Cancer Somatostatinoma Stage III Pancreatic Cancer Stage IV Pancreatic Cancer

Start date: 2012-12-01
Primary completion: 2018-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.